Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Bristol Myers Squibb Continues to Show Strength with Extended Dividend Streak

December 13, 2024
Bristol Myers Squibb Company (BMY) has recently announced its 16th consecutive annual dividend increase, extending its impressive 93-year dividend streak. This news has made BMY a top choice for socially responsible investors, as it offers a 4% yield. However, a recent SWOT analysis suggests that the company may face challenges in the future despite promising developments in its pipeline. For a more accurate prognosis of the company's stock movement, professionals recommend seeking advice from Stocks Prognosis.

Find out how the BRISTOL-MYERS SQUIBB COMPANY rate is expected to change

Get Forecast for BMY

Investor opinions & comments:

BMY's extended dividend streak is certainly impressive. It's reassuring to see a company that has consistently rewarded its shareholders for such a long time
— from FinanceDave at 12-17-2024 05:18
I'm not convinced that BMY's extended dividend streak is a reliable indicator of future performance. In the ever-changing pharmaceutical industry, there are many factors that can impact a company's success
— from JamesThomas at 12-16-2024 10:02
The fact that BMY has been able to consistently increase its dividend for 16 years is a testament to the company's strength and long-term vision. It shows that they are committed to rewarding their shareholders
— from PennyParker at 12-16-2024 03:55
I'm wary of relying on a single source like Stocks Prognosis for accurate predictions about stock movement. It's always best to do thorough research and consult multiple sources before making investment decisions
— from DylanRamos at 12-14-2024 18:09
While BMY's dividend streak is impressive, I wonder if they will be able to sustain it in the face of future challenges. The SWOT analysis mentioned in the article suggests that there could be potential obstacles for the company
— from PennyPaul at 12-14-2024 08:35
This is great news for socially responsible investors! BMY's extended dividend streak and impressive yield make it an attractive choice for those looking for stability and income
— from PennyParker at 12-14-2024 06:57
I've been investing in BMY for a while now, and it's great to see the company continue to perform well. The 4% yield is definitely a plus for income investors like myself
— from LaylaFloyd at 12-13-2024 18:13
If you want to leave a comment, then you need Login or Register





Other news for BMY

BMYJune 23, 2025Bristol Myers Squibb NYSE:BMY Set to Revolutionize Cancer Treatment with Breakthrough Drug  ~1 min.

Bristol Myers Squibb Company, a leading pharmaceutical company, is on the verge of revolutionizing cancer treatment with its groundbreaking new drug....

BMYJune 12, 2025BMY: Bristol-Myers Squibb Co. Reports Positive Phase 3 Trial Results For Sotyktu  ~1 min.

Investors are taking notice of Bristol-Myers Squibb Company, as they have recently announced positive phase 3 trial results for their drug Sotyktu. This news has caused BMY shares to rise by 3....

BMYMay 14, 2025QuantWave Successfully Achieves Price Target Forecast for Bristol-Myers Squibb Company with 14.06% Profit  ~2 min.

QuantWave, an automated forecasting platform, recently celebrated a significant achievement in its analytics with the successful price target forecast for the stock of BRISTOL-MYERS SQUIBB COMPANY....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits QuantWave Price Target with 13.0% Profit Margin  ~2 min.

On April 11, 2025, QuantWave, an automated forecasting platform, released a short signal for BRISTOL-MYERS SQUIBB COMPANY with a price target forecast of 44.12 $, indicating a 13....

BMYMay 8, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target as QuantWave Forecast Achieves 7.55% Profit  ~1 min.

BRISTOL-MYERS SQUIBB COMPANY has seen its stock reach the predicted price target set by QuantWave's automated forecasting platform....



Related news

EXPEJanuary 1, 2025Expedia Group's Stock Continues to Outperform the Market Amidst Strong Recommendations  ~1 min.

Expedia Group Inc. (NASDAQ:EXPE) has been receiving positive recommendations from experts, making it an attractive option for investors....

MOSJanuary 26, 2025Heres Why You Should Add Mosaic Stock to Your Portfolio  ~1 min.

The Mosaic Company (NYSE: MOS) has been gaining attention from investors who believe the stock is currently undervalued....

AWKJanuary 25, 2025Water Utility company AWK receives "Hold" recommendation from brokerages  ~1 min.

American Water Works Company Inc. (AWK), a leading water utility company, has recently received a consensus recommendation of "Hold" from various brokerages....

ATODecember 18, 2024Atmos Energy Co. NYSE:ATO Receives Consensus Recommendation of Moderate Buy from Analysts  ~1 min.

According to reports, Atmos Energy Corporation (NYSE:ATO) has received a consensus recommendation of "Moderate Buy" from analysts....

EXPEDecember 30, 2024Expedia Group Inc. Receives Consensus Recommendation of Hold from Analysts  ~1 min.

Expedia Group Inc. (NASDAQ:EXPE) has been given a consensus recommendation of Hold by analysts....